タンパク質発現市場 : 2027 年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年10月

タンパク質発現市場 : タイプ (大腸菌、哺乳類、CHO、HEK 293、昆虫、ピキア、無細胞)、製品 (試薬、ベクター、コンピテントセル、機器、サービス)、用途 (治療、産業)、エンドユーザー、地域別 – 2027 年までの世界予測
Protein Expression Market by Type (E.Coli, Mammalian, CHO, HEK 293, Insect, Pichia, Cell-free), Products (Reagents, Vectors, Competent Cells, Instruments, Service), Application (Therapeutic, Industrial), End User, and Region – Global Forecast to 2027

ページ数 314
図表数 394
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global Protein Expression market is valued at an estimated USD 2.9 billion in 2022 and is projected to reach USD 5.4 billion by 2027, at a CAGR of 13.3% during the forecast period. Factors such as the growth in the life science and biopharmaceutical industries, increasing research activities on recombinant-based protein expression, and the availability of funding for protein-based research. However, the high cost of protein expression reagents and instruments is expected to restrain the growth of this market.

タンパク質発現市場 : タイプ (大腸菌、哺乳類、CHO、HEK 293、昆虫、ピキア、無細胞)、製品 (試薬、ベクター、コンピテントセル、機器、サービス)、用途 (治療、産業)、エンドユーザー、地域別 - 2027 年までの世界予測

“The Prokaryotic Expression system segment accounted for the highest growth rate in the Protein Expression market, by System Type, during the forecast period”
In 2021, the Prokaryotic Expression system segment accounted for the highest growth rate. Factors such as high level of protein production at a minimal cost, and their increasing applications in biologics production will favor the growth of this market.

“Asia Pacific: The fastest-growing region in the Protein Expression market”
The Asia Pacific market is estimated to record the highest CAGR during the forecast period. The high growth rate of this market can be attributed to the rapid growth of the biotechnology industry, the rising prevalence of chronic disorders, increasing investments by governments in protein-based research, and rising awareness about personalized therapeutics. Besides, global players are focused on this region for the low-cost manufacturing advantage that it provides.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 60% and Demand Side 40%
• By Designation: C-level (Managers) – 45%, D-level (CXOs, Directors)- 30%, and Others (Executives) – 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, Middle East & Africa- 5%
List of Companies Profiled in the Report:
• Thermo Fisher Scientific, Inc (US)
• Merck KGaA (Germany)
• GenScript Biotech Corporation (US)
• Agilent Technologies, Inc. (US)
• Takara Bio, Inc. (Japan)
• Bio-Rad Laboratories, Inc. (US)
• Qiagen N.V (Netherlands)
• Charles River Laboratories, Inc. (US)
• Danaher Corporation (US)
• Sartorius AG (Germany)
• Corning Incorporated (US)
• FUJIFILM Irvine Scientific, Inc. (Japan)
• Lonza Group AG (Switzerland)
• Bioneer Corporation (South Korea)
• Promega Corporation (US)
• Oxford Expression Technologies Ltd. (UK)
• ProteoGenix (France)
• Abeomics, Inc. (US)
• New England Biolabs, Inc. (US)
• Promab Biotechnologies (US)
• Sino Biological, Inc. (China)
• Jena Bioscience (Germany)
• Lifesensors, Inc. (US)
• Leading biology, Inc. (US)
• Peak Proteins (UK)

タンパク質発現市場 : タイプ (大腸菌、哺乳類、CHO、HEK 293、昆虫、ピキア、無細胞)、製品 (試薬、ベクター、コンピテントセル、機器、サービス)、用途 (治療、産業)、エンドユーザー、地域別 - 2027 年までの世界予測
Research Coverage:
This report provides a detailed picture of the global Protein Expression Market. It aims at estimating the size and future growth potential of the market across different segments such as the system type, product & service, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall Protein Expression Market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, challenges, restraints, trends, and opportunities.


目次

1 INTRODUCTION 43
1.1 STUDY OBJECTIVES 43
1.2 MARKET DEFINITION 43
1.2.1 INCLUSIONS AND EXCLUSIONS 43
1.3 MARKET SCOPE 44
1.3.1 MARKETS COVERED 44
1.3.2 YEARS CONSIDERED 45
1.4 CURRENCY CONSIDERED 45
1.5 LIMITATIONS 45
1.6 STAKEHOLDERS 45
1.7 SUMMARY OF CHANGES 46
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
FIGURE 1 RESEARCH DESIGN 47
2.1.1 SECONDARY DATA 47
2.1.2 PRIMARY DATA 48
FIGURE 2 BREAKDOWN OF PRIMARIES 49
2.2 MARKET ESTIMATION METHODOLOGY 50
FIGURE 3 PROTEIN EXPRESSION MARKET SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2021 50
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2021 51
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 52
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 52
2.3 MARKET GROWTH RATE PROJECTIONS 53
FIGURE 6 PROTEIN EXPRESSION MARKET (SUPPLY SIDE): CAGR PROJECTIONS 53
FIGURE 7 PROTEIN EXPRESSION MARKET (DEMAND SIDE): GROWTH ANALYSIS OF FACTORS 54
2.3.1 DATA TRIANGULATION 55
FIGURE 8 DATA TRIANGULATION METHODOLOGY 55
2.4 RESEARCH ASSUMPTIONS 56
2.4.1 COVID-19-SPECIFIC ASSUMPTIONS 56
2.5 RISK ANALYSIS 57
3 EXECUTIVE SUMMARY 58
FIGURE 9 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 10 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 59
FIGURE 11 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 59
FIGURE 12 PROTEIN EXPRESSION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 60
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF PROTEIN EXPRESSION MARKET 61
4 PREMIUM INSIGHTS 62
4.1 PROTEIN EXPRESSION MARKET OVERVIEW 62
FIGURE 14 INCREASING DEMAND FOR PROTEIN BIOLOGICS TO DRIVE MARKET 62
4.2 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021) 63
FIGURE 15 US TO COMMAND LARGEST SHARE OF NORTH AMERICAN PROTEIN EXPRESSION MARKET IN 2021 63
4.3 PROTEIN EXPRESSION MARKET SHARE, BY SYSTEM TYPE, 2022 VS. 2027 64
FIGURE 16 MAMMALIAN CELL EXPRESSION SYSTEM TO DOMINATE MARKET IN 2027 64
4.4 PROTEIN EXPRESSION MARKET SHARE, BY END USER, 2022 64
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS 64
4.5 PROTEIN EXPRESSION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 65
5 MARKET OVERVIEW 66
5.1 INTRODUCTION 66
5.2 MARKET DYNAMICS 66
FIGURE 19 PROTEIN EXPRESSION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 66
5.2.1 DRIVERS 67
5.2.1.1 Increasing demand for protein biologics 67
TABLE 1 BIOLOGICS AND CELL LINES USED 67
TABLE 2 BIOLOGICS APPROVED BY FDA IN 2021 68
TABLE 3 PROTEINS SYNTHESIZED BY PROTEIN EXPRESSION AND GENETIC ENGINEERING 69
FIGURE 20 DIABETES CASES, BY REGION, 2021 VS. 2045 (MILLION) 69
TABLE 4 GLOBAL INCIDENCE OF CANCER, BY TYPE (2020) 70
5.2.1.2 Increasing R&D in pharmaceutical and biopharmaceutical industries 70
5.2.1.3 Growing adoption of recombinant-based protein expression 71
5.2.1.4 Availability of funding for protein-based research 71
TABLE 5 GOVERNMENT FUNDING FOR PROTEIN-BASED RESEARCH (2017–2022) 72
5.2.2 RESTRAINTS 73
5.2.2.1 High cost of protein expression reagents and instruments 73
TABLE 6 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000 L IN DEVELOPED AND DEVELOPING COUNTRIES (2020) 73
5.2.2.2 Increasing consolidation and high barriers for new entrants 74
5.2.3 OPPORTUNITIES 74
5.2.3.1 Emergence of microfluidics 74
5.2.3.2 Emerging economies offering significant growth potential 74
5.2.4 CHALLENGE 75
5.2.4.1 Undesired post-translational modifications and purification 75
5.3 RANGES/SCENARIOS 76
FIGURE 21 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PROTEIN EXPRESSION MARKET 76
FIGURE 22 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 76
5.4 PRICING ANALYSIS 77
5.5 TECHNOLOGY ANALYSIS 77
TABLE 7 ADVANTAGES AND CHALLENGES OF RECOMBINANT PROTEIN EXPRESSION SYSTEMS 77
5.6 PATENT ANALYSIS 79
FIGURE 23 PATENT APPLICATIONS FOR PROTEIN EXPRESSION MARKET, JANUARY 2011–MAY 2022 79
TABLE 8 INDICATIVE PATENT IN PROTEIN EXPRESSION MARKET 79
5.7 VALUE CHAIN ANALYSIS 80
FIGURE 24 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE TO CONTRIBUTE MAXIMUM VALUE 80
5.8 SUPPLY CHAIN ANALYSIS 81
FIGURE 25 PROTEIN EXPRESSION MARKET: SUPPLY CHAIN ANALYSIS 82
5.9 ECOSYSTEM ANALYSIS 82
TABLE 9 SUPPLY CHAIN ECOSYSTEM 83
5.10 KEY CONFERENCES AND EVENTS IN 2022–2023 84
TABLE 10 PROTEIN EXPRESSION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 84
5.11 REGULATORY ANALYSIS 85
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
5.12 PORTER’S FIVE FORCES ANALYSIS 87
TABLE 15 PROTEIN EXPRESSION MARKET: PORTER’S FIVE FORCES ANALYSIS 87
5.12.1 THREAT OF NEW ENTRANTS 87
5.12.2 THREAT OF SUBSTITUTES 87
5.12.3 BARGAINING POWER OF SUPPLIERS 87
5.12.4 BARGAINING POWER OF BUYERS 87

5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 88
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
FIGURE 26 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF PROTEIN EXPRESSION PRODUCTS AND SERVICES 88
5.13.2 BUYING CRITERIA FOR PROTEIN EXPRESSION PRODUCTS 88
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 88
6 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE 89
6.1 INTRODUCTION 90
TABLE 16 PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 90
6.2 MAMMALIAN CELL EXPRESSION SYSTEMS 90
TABLE 17 PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 91
TABLE 18 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 91
TABLE 19 EUROPE: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 20 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 21 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 93
TABLE 22 MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93
6.2.1 CHINESE HAMSTER OVARY CELL SYSTEMS (CHO CELL SYSTEMS) 93
6.2.1.1 Chinese hamster ovary cell systems to dominate market 93
TABLE 23 PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 94
TABLE 24 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 25 EUROPE: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 26 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 27 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CHO CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 95
6.2.2 HUMAN EMBRYONIC KIDNEY CELL SYSTEMS (HEK 293 CELL SYSTEMS) 95
6.2.2.1 Increasing use of HEK 293 cells for producing biologics to boost market 95
TABLE 28 PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 96
TABLE 29 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 30 EUROPE: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 31 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 32 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR HEK 293 CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 98
6.2.3 OTHER MAMMALIAN CELL SYSTEMS 98
TABLE 33 PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 34 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 35 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 36 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 37 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER MAMMALIAN CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 100
6.3 PROKARYOTIC EXPRESSION SYSTEMS 100
TABLE 38 PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 101
TABLE 39 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 40 EUROPE: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 41 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 42 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 103
TABLE 43 PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 103
6.3.1 ESCHERICHIA COLI SYSTEMS 103
6.3.1.1 Increasing use of E. coli systems for commercial protein production to fuel market 103
TABLE 44 PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 45 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 46 EUROPE: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 47 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 48 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR E. COLI SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 105
6.3.2 OTHER PROKARYOTIC EXPRESSION SYSTEMS 105
TABLE 49 PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 106
TABLE 50 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 51 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 52 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 53 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER PROKARYOTIC EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 108
6.4 INSECT CELL EXPRESSION SYSTEMS 108
TABLE 54 PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 55 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 56 EUROPE: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 57 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 58 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INSECT CELL EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 110
TABLE 59 INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
6.4.1 BACULOVIRUS SYSTEMS 111
6.4.1.1 Baculovirus systems to show high yield and expression levels for intracellular proteins 111
TABLE 60 PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 111
TABLE 61 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 62 EUROPE: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 63 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 64 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR BACULOVIRUS SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 113
6.4.2 OTHER INSECT CELL SYSTEMS 113
TABLE 65 PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 66 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 67 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 68 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 69 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER INSECT CELL SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 115
6.5 YEAST EXPRESSION SYSTEMS 115
TABLE 70 PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 116
TABLE 71 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 72 EUROPE: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 73 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 74 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 118
TABLE 75 YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118
6.5.1 PICHIA SYSTEMS 118
6.5.1.1 Pichia systems to hold largest market share 118
TABLE 76 PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 119
TABLE 77 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 78 EUROPE: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 79 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 80 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PICHIA SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 120
6.5.2 SACCHAROMYCES SYSTEMS 120
6.5.2.1 Saccharomyces systems to channelize direction of foreign proteins into secretory pathways using various signals 120
TABLE 81 PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 121
TABLE 82 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 83 EUROPE: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 84 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 85 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR SACCHAROMYCES SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 122
6.5.3 OTHER YEAST EXPRESSION SYSTEMS 122
TABLE 86 PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 123
TABLE 87 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 88 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 89 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 90 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR OTHER YEAST EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 124
6.6 CELL-FREE EXPRESSION SYSTEMS 124
6.6.1 INCREASING DEMAND FOR RECOMBINANT PROTEINS TO SUPPORT MARKET 124
TABLE 91 PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 125
TABLE 92 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 93 EUROPE: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 94 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 95 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CELL-FREE EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 126
6.7 ALGAL-BASED EXPRESSION SYSTEMS 126
6.7.1 GROWTH IN VACCINES MARKET TO SUPPORT SEGMENT 126
TABLE 96 PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 127
TABLE 97 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 98 EUROPE: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 99 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY COUNTRY, 2020–2027 (USD MILLION) 128
TABLE 100 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR ALGAL-BASED EXPRESSION SYSTEMS, BY REGION, 2020–2027 (USD MILLION) 128
7 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE 129
7.1 INTRODUCTION 130
TABLE 101 PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 130
7.2 REAGENTS 130
7.2.1 REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD 130
TABLE 102 PROTEIN EXPRESSION REAGENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 131
TABLE 103 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 104 EUROPE: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 105 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 106 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION) 132
7.3 EXPRESSION VECTORS 132
7.3.1 EXPRESSION VECTORS TO BE INDISPENSABLE FOR PROTEIN EXPRESSION 132
TABLE 107 PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION, 2020–2027 (USD MILLION) 133
TABLE 108 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 109 EUROPE: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 134
TABLE 110 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2020–2027 (USD MILLION) 134
TABLE 111 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION, 2020–2027 (USD MILLION) 134

7.4 COMPETENT CELLS 135
7.4.1 INCREASING DEMAND FOR THERAPEUTIC PROTEINS TO DRIVE MARKET 135
TABLE 112 PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 113 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 114 EUROPE: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 115 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 137
TABLE 116 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION, 2020–2027 (USD MILLION) 137
7.5 INSTRUMENTS 137
7.5.1 INSTRUMENTS TO EFFICIENTLY TRANSFER GENETIC MATERIALS INTO HOST CELLS 137
TABLE 117 PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 138
TABLE 118 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 119 EUROPE: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 120 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 121 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION) 140
7.6 SERVICES 140
7.6.1 RISING DEMAND FOR CUSTOMIZED PROTEINS TO PROPEL MARKET 140
TABLE 122 PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION) 140
TABLE 123 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 124 EUROPE: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 125 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION) 142
TABLE 126 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION) 142
8 PROTEIN EXPRESSION MARKET, BY APPLICATION 143
8.1 INTRODUCTION 144
TABLE 127 PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144
8.2 THERAPEUTIC APPLICATIONS 144
8.2.1 THERAPEUTIC PROTEINS TO TREAT PATHOLOGICAL CONDITIONS 144
TABLE 128 THERAPEUTIC PROTEINS AND INDICATION 145
TABLE 129 PROTEIN EXPRESSION MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 146
TABLE 130 NORTH AMERICA: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 131 EUROPE: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
TABLE 132 ASIA PACIFIC: THERAPEUTIC APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 133 REST OF THE WORLD: THERAPEUTIC APPLICATIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 147
8.3 RESEARCH APPLICATIONS 147
8.3.1 INCREASING INVESTMENTS IN RESEARCH ACTIVITIES TO DRIVE SEGMENT 147
TABLE 134 PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 148
TABLE 135 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 136 EUROPE: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 137 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 138 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 150
8.4 INDUSTRIAL APPLICATIONS 150
8.4.1 GROWTH IN EXPRESSION SYSTEMS FOR INDUSTRIAL ENZYMES PRODUCTION TO SUPPORT SEGMENT 150
TABLE 139 PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 151
TABLE 140 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 141 EUROPE: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 142 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 152
TABLE 143 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 152
9 PROTEIN EXPRESSION MARKET, BY END USER 153
9.1 INTRODUCTION 154
TABLE 144 PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 154
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 154
9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END USERS MARKET 154
TABLE 145 PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 155
TABLE 146 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 147 EUROPE: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 155
TABLE 148 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 149 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 156
9.3 ACADEMIC RESEARCH INSTITUTES 156
9.3.1 INCREASING GOVERNMENT AND PRIVATE FUNDING TO SUPPORT MARKET 156
TABLE 150 PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 157
TABLE 151 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 152 EUROPE: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 153 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 158
TABLE 154 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 159
9.4 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CROS & CDMOS) 159
9.4.1 CLINICAL TRIALS, OUTSOURCING, AND COLLABORATIONS FOR PHARMACEUTICAL MANUFACTURING TO BOOST MARKET 159
TABLE 155 PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY REGION, 2020–2027 (USD MILLION) 160
TABLE 156 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 157 EUROPE: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 158 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY COUNTRY, 2020–2027 (USD MILLION) 161
TABLE 159 REST OF THE WORLD: PROTEIN EXPRESSION MARKET FOR CROS & CDMOS, BY REGION, 2020–2027 (USD MILLION) 161
9.5 OTHER END USERS 161
TABLE 160 PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 162
TABLE 161 NORTH AMERICA: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 162 EUROPE: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 163 ASIA PACIFIC: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 163
TABLE 164 ROW: PROTEIN EXPRESSION MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION) 163
10 PROTEIN EXPRESSION MARKET, BY REGION 164
10.1 INTRODUCTION 165
TABLE 165 PROTEIN EXPRESSION MARKET, BY REGION, 2020–2027 (USD MILLION) 165
10.2 NORTH AMERICA 165
FIGURE 28 NORTH AMERICA: PROTEIN EXPRESSION MARKET SNAPSHOT 166
TABLE 166 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 166
TABLE 167 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 167
TABLE 168 NORTH AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 169 NORTH AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 170 NORTH AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 171 NORTH AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 172 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169
TABLE 173 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 169
TABLE 174 NORTH AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 170
10.2.1 US 170
10.2.1.1 US to dominate global protein expression market 170
TABLE 175 US: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 171
TABLE 176 US: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 177 US: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 178 US: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 179 US: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 180 US: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 173
TABLE 181 US: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 173
TABLE 182 US: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 174
10.2.2 CANADA 174
10.2.2.1 Government funding for research and innovation to support market 174
TABLE 183 CANADA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 175
TABLE 184 CANADA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 185 CANADA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 186 CANADA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 187 CANADA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 188 CANADA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 177
TABLE 189 CANADA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177
TABLE 190 CANADA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 178
10.3 EUROPE 178
TABLE 191 EUROPE: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 192 EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 179
TABLE 193 EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 194 EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 195 EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 196 EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 197 EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 181
TABLE 198 EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 181
TABLE 199 EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 182
10.3.1 GERMANY 182
10.3.1.1 Germany to dominate market share in Europe 182
TABLE 200 GERMANY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 183
TABLE 201 GERMANY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 202 GERMANY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 203 GERMANY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 204 GERMANY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 205 GERMANY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 185
TABLE 206 GERMANY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 185
TABLE 207 GERMANY: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 186
10.3.2 UK 186
10.3.2.1 Surge in number of chronic diseases to boost market 186
TABLE 208 UK: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 187
TABLE 209 UK: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 210 UK: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 211 UK: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 212 UK: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 213 UK: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 189
TABLE 214 UK: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 189
TABLE 215 UK: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 190
10.3.3 FRANCE 190
10.3.3.1 Increasing biotech R&D to drive market 190
TABLE 216 FRANCE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 191
TABLE 217 FRANCE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 218 FRANCE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 219 FRANCE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 220 FRANCE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 221 FRANCE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 193
TABLE 222 FRANCE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 193
TABLE 223 FRANCE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 194
10.3.4 ITALY 194
10.3.4.1 Increase in life sciences research projects to fuel market 194
TABLE 224 ITALY: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 195
TABLE 225 ITALY: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 226 ITALY: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 227 ITALY: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 228 ITALY: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 229 ITALY: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 197
TABLE 230 ITALY: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 231 ITALY: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 198

10.3.5 SPAIN 198
10.3.5.1 Network of research centers, universities, and hospitals to propel market 198
TABLE 232 SPAIN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 199
TABLE 233 SPAIN: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 234 SPAIN: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 235 SPAIN: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 236 SPAIN: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 200
TABLE 237 SPAIN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 201
TABLE 238 SPAIN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 201
TABLE 239 SPAIN: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 202
10.3.6 REST OF EUROPE 202
TABLE 240 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 203
TABLE 241 REST OF EUROPE: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 203
TABLE 242 REST OF EUROPE: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 243 REST OF EUROPE: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 244 REST OF EUROPE: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 245 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 205
TABLE 246 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 205
TABLE 247 REST OF EUROPE: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 206
10.4 ASIA PACIFIC 206
FIGURE 29 ASIA PACIFIC: PROTEIN EXPRESSION MARKET SNAPSHOT 207
TABLE 248 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 208
TABLE 249 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 208
TABLE 250 ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 251 ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 252 ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 209
TABLE 253 ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 254 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 210
TABLE 255 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 210
TABLE 256 ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 211
10.4.1 CHINA 211
10.4.1.1 Growth in R&D to enhance technological capabilities 211
TABLE 257 CHINA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 212
TABLE 258 CHINA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 259 CHINA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 260 CHINA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 261 CHINA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 262 CHINA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 214
TABLE 263 CHINA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 214
TABLE 264 CHINA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 215
10.4.2 JAPAN 215
10.4.2.1 Increasing protein-based research to stimulate market 215
TABLE 265 JAPAN: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 216
TABLE 266 JAPAN: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 216
TABLE 267 JAPAN: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 268 JAPAN: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 269 JAPAN: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 217
TABLE 270 JAPAN: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 218
TABLE 271 JAPAN: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 218
TABLE 272 JAPAN: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 219
10.4.3 INDIA 219
10.4.3.1 Increasing government support to drive market 219
TABLE 273 INDIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 220
TABLE 274 INDIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 220
TABLE 275 INDIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 276 INDIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 277 INDIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 278 INDIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 222
TABLE 279 INDIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 222
TABLE 280 INDIA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 223
10.4.4 AUSTRALIA 223
10.4.4.1 Increasing focus of healthcare system on precision medicine to fuel market 223
TABLE 281 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 224
TABLE 282 AUSTRALIA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 224
TABLE 283 AUSTRALIA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 284 AUSTRALIA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 285 AUSTRALIA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 225
TABLE 286 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 226
TABLE 287 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 226
TABLE 288 AUSTRALIA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 227
10.4.5 REST OF ASIA PACIFIC 227
TABLE 289 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 228
TABLE 290 REST OF ASIA PACIFIC: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 228
TABLE 291 REST OF ASIA PACIFIC: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 292 REST OF ASIA PACIFIC: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 293 REST OF ASIA PACIFIC: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 229
TABLE 294 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 230
TABLE 295 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 230
TABLE 296 REST OF ASIA PACIFIC: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 231
10.5 REST OF THE WORLD 231
TABLE 297 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY REGION, 2020–2027 (USD MILLION) 231
TABLE 298 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 232
TABLE 299 REST OF THE WORLD: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 232
TABLE 300 REST OF THE WORLD: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 301 REST OF THE WORLD: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 302 REST OF THE WORLD: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 233
TABLE 303 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 234
TABLE 304 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 234
TABLE 305 REST OF THE WORLD: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 235
10.5.1 LATIN AMERICA 235
10.5.1.1 Growth in biopharmaceutical industry to support market 235
TABLE 306 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 236
TABLE 307 LATIN AMERICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 236
TABLE 308 LATIN AMERICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 309 LATIN AMERICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 310 LATIN AMERICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 311 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 238
TABLE 312 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 238
TABLE 313 LATIN AMERICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 239
10.5.2 MIDDLE EAST & AFRICA 239
10.5.2.1 Increasing government investments in healthcare sector and growing pharmaceuticals industry to support market 239
TABLE 314 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION) 240
TABLE 315 MIDDLE EAST & AFRICA: MAMMALIAN CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 316 MIDDLE EAST & AFRICA: PROKARYOTIC EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 317 MIDDLE EAST & AFRICA: INSECT CELL EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 318 MIDDLE EAST & AFRICA: YEAST EXPRESSION SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION) 241
TABLE 319 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 242
TABLE 320 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 242
TABLE 321 MIDDLE EAST & AFRICA: PROTEIN EXPRESSION MARKET, BY END USER, 2020–2027 (USD MILLION) 243
11 COMPETITIVE LANDSCAPE 244
11.1 OVERVIEW 244
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 244
11.3 MARKET SHARE ANALYSIS 245
TABLE 322 PROTEIN EXPRESSION MARKET: DEGREE OF COMPETITION 245
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 247
11.5 COMPANY EVALUATION QUADRANT 247
11.5.1 STARS 248
11.5.2 EMERGING LEADERS 248
11.5.3 PERVASIVE PLAYERS 248
11.5.4 PARTICIPANTS 248
FIGURE 33 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION QUADRANT, 2021 249
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 250
11.6.1 PROGRESSIVE COMPANIES 250
11.6.2 STARTING BLOCKS 250
11.6.3 RESPONSIVE COMPANIES 250
11.6.4 DYNAMIC COMPANIES 250
FIGURE 34 PROTEIN EXPRESSION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 251
11.7 COMPANY FOOTPRINT ANALYSIS 252
11.7.1 PRODUCT FOOTPRINT OF COMPANIES 252
TABLE 323 PRODUCT AND SERVICE FOOTPRINT OF COMPANIES IN PROTEIN EXPRESSION MARKET (2021) 252
11.8 REGIONAL FOOTPRINT OF COMPANIES 253
TABLE 324 REGIONAL FOOTPRINT OF COMPANIES IN PROTEIN EXPRESSION MARKET (2021) 253
11.9 COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS 255
TABLE 325 PROTEIN EXPRESSION MARKET: DETAILED LIST OF KEY START-UPS/SME PLAYERS 255
11.10 COMPETITIVE SCENARIO 255
TABLE 326 KEY PRODUCT/ SERVICE LAUNCHES 255
TABLE 327 KEY DEALS 256
TABLE 328 EXPANSION 256
12 COMPANY PROFILES 257
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
12.1 KEY PLAYERS 257
12.1.1 THERMO FISHER SCIENTIFIC, INC. 257
TABLE 329 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW 257
FIGURE 35 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 258
12.1.2 MERCK KGAA 262
TABLE 330 MERCK KGAA: COMPANY OVERVIEW 262
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT 263
12.1.3 GENSCRIPT BIOTECH CORPORATION 266
TABLE 331 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW 266
FIGURE 37 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2021) 267
12.1.4 AGILENT TECHNOLOGIES INC. 269
TABLE 332 AGILENT TECHNOLOGIES INC.: COMPANY OVERVIEW 269
FIGURE 38 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2021) 270
12.1.5 TAKARA BIO, INC. 272
TABLE 333 TAKARA BIO, INC.: COMPANY OVERVIEW 272
FIGURE 39 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021) 273
12.1.6 BIO-RAD LABORATORIES, INC. 275
TABLE 334 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 275
FIGURE 40 TAKARA BIO, INC.: COMPANY SNAPSHOT (2021) 276
12.1.7 QIAGEN N.V. 278
TABLE 335 QIAGEN N.V.: COMPANY OVERVIEW 278
FIGURE 41 QIAGEN N.V..: COMPANY SNAPSHOT (2021) 279
12.1.8 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 281
TABLE 336 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW 281
FIGURE 42 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT (2021) 282
12.1.9 DANAHER CORPORATION 283
TABLE 337 DANAHER CORPORATION: COMPANY OVERVIEW 283
FIGURE 43 DANAHER CORPORATION: COMPANY SNAPSHOT 284
12.1.10 SARTORIUS AG 288
TABLE 338 SARTORIUS AG: COMPANY OVERVIEW 288
FIGURE 44 SARTORIUS AG: COMPANY SNAPSHOT 289
12.1.11 CORNING INCORPORATED 292
TABLE 339 CORNING INCORPORATED: COMPANY OVERVIEW 292
FIGURE 45 CORNING INCORPORATED: COMPANY SNAPSHOT 293
12.1.12 FUJIFILM IRVINE SCIENTIFIC, INC. (ACQUIRED BY FUJIFILM HOLDINGS CORPORATION) 295
TABLE 340 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 295
FIGURE 46 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 296
12.1.13 LONZA GROUP AG 300
TABLE 341 LONZA GROUP AG: COMPANY OVERVIEW 300
FIGURE 47 LONZA GROUP AG: COMPANY SNAPSHOT (2021) 301
12.1.14 BIONEER CORPORATION 303
TABLE 342 BIONEER CORPORATION: COMPANY OVERVIEW 303
12.1.15 PROMEGA CORPORATION 305
TABLE 343 PROMEGA CORPORATION: COMPANY OVERVIEW 305
12.1.16 OXFORD EXPRESSION TECHNOLOGIES LTD. 307
TABLE 344 OXFORD EXPRESSION TECHNOLOGIES LTD.: COMPANY OVERVIEW 307
12.1.17 PROTEOGENIX 309
TABLE 345 PROTEOGENIX: COMPANY OVERVIEW 309
12.1.18 ABEOMICS INC. 311
TABLE 346 ABEOMICS INC.: COMPANY OVERVIEW 311
12.1.19 NEW ENGLAND BIOLABS, INC. 312
TABLE 347 NEW ENGLAND BIOLABS, INC.: COMPANY OVERVIEW 312
12.2 OTHER PLAYERS 313
12.2.1 PROMAB BIOTECHNOLOGIES 313
12.2.2 SINO BIOLOGICAL, INC. 314
12.2.3 JENA BIOSCIENCE 315
12.2.4 LIFESENSORS, INC. 315
12.2.5 LEADING BIOLOGY, INC. 317
12.2.6 PEAK PROTEINS 318
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
13 APPENDIX 319
13.1 DISCUSSION GUIDE 319
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 324
13.3 AVAILABLE CUSTOMIZATIONS 326
13.4 RELATED REPORTS 326
13.5 AUTHOR DETAILS 327


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com